A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Bevacizumab in Adult Participants With Ovarian Cancer
Clinical trial NCT07278336 · RECRUITING
Trial details
- NCT number
- NCT07278336
- Sponsor
- AbbVie
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-27
- Primary completion
- 2029-01-01
- Enrollment
- 219
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.